Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.

by Eva Juengel, Jasmina Makarević, Igor Tsaur, Georg Bartsch, Karen Nelson, Axel Haferkamp, Roman A Blaheta
Published 2013-01-01

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

by Christian Thomas, Georg Bartsch, Christian Walter, Hendrik Borgmann, Maximilian Peter Brandt, Thomas Höfner, Axel Haferkamp, Igor Tsaur
Published 2016-08-01

Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

by Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Published 2014-04-01

I publish in I edit?--Do editorial board members of urologic journals preferentially publish their own scientific work?

by Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Published 2013-01-01

Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2.

by Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Published 2014-01-01

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics

by Stefan Vallo, Martin Michaelis, Florian Rothweiler, Georg Bartsch, Kilian M. Gust, Dominik M. Limbart, Franz Rödel, Felix Wezel, Axel Haferkamp, Jindrich Cinatl, Jr
Published 2015-06-01

Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer

by Igor Tsaur, Carmen Biegel, Kilian Gust, Tanja Huesch, Hendrik Borgmann, Maximilian P.J.K. Brandt, Martin Kurosch, Michael Reiter, Georg Bartsch, David Schilling, Axel Haferkamp
Published 2015-06-01